Mechanisms of Injury in Hypoxic-Ischemic Encephalopathy: Implications to Therapy

 

 Buy Article Permissions and Reprints

ABSTRACT

Cardiac arrest survivors commonly suffer ischemic brain injury, and understanding the mechanisms of injury is essential to providing insight for effective therapies for brain protection. Injury can occur at the time of the cardiac arrest and is dependent not only on the duration but also the degree of impaired circulation. Injury can be ongoing even after the return of spontaneous circulation, giving the clinician an additional window of opportunity to treat and protect the injured brain. This section will review the molecular basis of injury with cardiac arrest and will elucidate the different mechanisms of injury between cardiac arrest, pure respiratory arrest, and arrest secondary to toxins (e.g., carbon monoxide). The rationale for multiple postarrest therapies, such as hypothermia and induced hypertension, will also be reviewed.

REFERENCES

• 1 Wagner IV S R, Lanier W L. Metabolism of glucose, glycogen, and high-energy phosphates during complete cerebral ischemia: a comparison of normoglycemic, chronically hyperglycemic diabetic, and acutely hyperglycemic nondiabetic rats.  Anesthesiology. 1994;  81 1516-1526
  CrossrefPubMedGoogle Scholar
• 2 Hoxworth J M, Xu K, Zhou Y et al.. Cerebral metabolic profile, selective neuron loss, and survival of acute and chronic hyperglycemic rats following cardiac arrest and resuscitation.  Brain Res. 1999;  821 467-479
  CrossrefPubMedGoogle Scholar
• 3 Siesjö B K. Brain Energy Metabolism. New York; John Wiley 1978
  Google Scholar
• 4 Hossmann K A, Zimmermann V. Resuscitation of the monkey brain after 1 hour complete ischemia.  Brain Res. 1974;  81 59-74
  CrossrefPubMedGoogle Scholar
• 5 Hossmann K A, Schmidt-Kastner R, Grosse Optoff B. Recovery of integrative central nervous function after one hour global cerebro-circulatory arrest in normothermic cat.  J Neurol Sci. 1987;  77 305-320
  CrossrefPubMedGoogle Scholar
• 6 Caplan L R. Reperfusion of ischemic brain: why and why not. In: Hacke W, del Zoppo GJ, Hirschberg M Thrombolytic Therapy in Acute Ischemic Stroke. Berlin; Springer-Verlag 1991: 36-45
  Google Scholar
• 7 Ames III A, Wright L W, Kowada M et al.. Cerebral ischemia: II. The no-reflow phenomenon.  Am J Pathol. 1968;  52 437-453
  PubMedGoogle Scholar
• 8 Ginsberg M D, Myers R E. The topography of impaired microvascular perfusion in the primate brain following total circulatory arrest.  Neurology. 1972;  22 998-1011
  PubMedGoogle Scholar
• 9 Petito C K, Feldmann E, Pulsinelli W et al.. Delayed hippocampal damage in humans following cardiorespiratory arrest.  Neurology. 1987;  37 1281-1286
  PubMedGoogle Scholar
• 10 Plum F, Posner J B, Hain R F. Delayed neurological deterioration after anoxia.  Arch Intern Med. 1962;  110 18-22
  PubMedGoogle Scholar
• 11 Ginsberg M D, Hedley-Whyte E T, Richardson E P. Hypoxic-ischemic leukoencephalopathy in man.  Arch Neurol. 1976;  33 5-14
  PubMedGoogle Scholar
• 12 Chalela J A, Wolf R L, Maldjian J A et al.. MRI identification of early white matter injury in anoxic-ischemic encephalopathy.  Neurology. 2001;  56 481-485
  CrossrefPubMedGoogle Scholar
• 13 Adams J H, Brierley J B, Connor R CR et al.. The effects of systemic hypotension upon the human brain: clinical and neuropathological observations in 11 cases.  Brain. 1966;  89 235-268
  CrossrefPubMedGoogle Scholar
• 14 Miller J R, Myers R E. Neuropathology of systemic circulatory arrest in adult monkeys.  Neurology. 1972;  22 888-904
  PubMedGoogle Scholar
• 15 Pearigen P, Ryder G, Simon R P. The effects in vivo of hypoxia on brain injury (research report).  Brain Res. 1996;  725 184-191
  PubMedGoogle Scholar
• 16 Bergeron M, Ferriero D M, Sharp F R. Developmental expression of heme oxygenase-1 (HSP 32) in rat brain: an immunocytochemical study.  Brain Res Dev Brain Res. 1998;  105 181-194
  PubMedGoogle Scholar
• 17 Miyamoto O, Auer R N. Hypoxia, hyperoxia, ischemia, and brain necrosis.  Neurology. 2000;  54 362-371
  PubMedGoogle Scholar
• 18 Gray Jr F D, Horner G J. Survival following extreme hypoxia.  JAMA. 1970;  211 1815-1817
  CrossrefPubMedGoogle Scholar
• 19 Rie M A, Bernad P G. Prolonged hypoxia in man without circulatory compromise fail to demonstrate cerebral pathology.  Neurology. 1980;  30 443
  PubMedGoogle Scholar
• 20 Pace N, Strajman E, Walker E L. Acceleration of carbon monoxide elimination in man by high pressure oxygen.  Science. 1950;  111 652-654
  CrossrefPubMedGoogle Scholar
• 21 Tibbles P M, Edelsberg J S. Hyperbaric-oxygen therapy.  N Engl J Med. 1996;  334 1642-1648
  CrossrefPubMedGoogle Scholar
• 22 Weaver L K, Hopkins R O, Chan K J et al.. Hyperbaric oxygen for acute carbon monoxide poisoning.  N Engl J Med. 2002;  347 1057-1067
  CrossrefPubMedGoogle Scholar
• 23 Monsalve F, Rucabado L, Ruano M et al.. The neurological effects of thiopental therapy after cardiac arrest.  Intensive Care Med. 1987;  13 244-248
  CrossrefPubMedGoogle Scholar
• 24 The Brain Resuscitation Clinical Trial I Study Group . Randomized clinical study of thiopental loading in comatose survivors of cardiac arrest.  N Engl J Med. 1986;  314 397-403
  PubMedGoogle Scholar
• 25 The Brain Resuscitation Clinical Trial II Study Group . A randomized clinical study of a calcium-entry blocker (Lidoflazine) in the treatment of comatose survivors of cardiac arrest.  N Engl J Med. 1991;  324 1225-1231
  PubMedGoogle Scholar
• 26 Longstreth Jr W T, Fahrenbruch C E, Olsufka M et al.. Randomized clinical trial of magnesium, diazepam, or both after out-of-hospital cardiac arrest.  Neurology. 2002;  59 506-514
  PubMedGoogle Scholar
• 27 Helfaer M A, Ichord R N, Martin L J et al.. Treatment with the competitive NMDA antagonist GPI 3000 does not improve outcome after cardiac arrest in dogs.  Stroke. 1998;  29 824-829
  PubMedGoogle Scholar
• 28 Ross D T, Brasko J, Patrikios P. The AMPA antagonist NBQX protects thalamic reticular neurons from degeneration following cardiac arrest in rats.  Brain Res. 1995;  683 117-128
  CrossrefPubMedGoogle Scholar
• 29 Jover T, Tanaka H, Calderone A et al.. Estrogen protects against global ischemia-induced neuronal death and prevents activation of apoptotic signaling cascades in the hippocampal CA1.  J Neurosci. 2002;  22 2115-2124
  PubMedGoogle Scholar
• 30 Katz L M, Lotocki G, Wang Y et al.. Regulation of caspases and XIAP in the brain after asphyxial cardiac arrest in rats.  Neuroreport. 2001;  12 3751-3754
  PubMedGoogle Scholar
• 31 Crumrine R C, Bergstrand K, Cooper A T et al.. Lamotrigine protects hippocampal CA1 neurons from ischemic damage after cardiac arrest.  Stroke. 1997;  28 2230-2236
  PubMedGoogle Scholar
• 32 Uchino H, Ishii N, Shibasaki F. Calcineurin and cyclophilin D are differential targets of neuroprotection by immunosuppressants CsA and FK 506 in ischemic brain damage.  Acta Neurochir Suppl. 2003;  86 105-111
  PubMedGoogle Scholar
• 33 Chan P H, Kawase M, Murakami K et al.. Overexpression of SOD1 in transgenic rats protects vulnerable neurons against ischemic damage after global cerebral ischemia and reperfusion.  J Neurosci. 1998;  18 8292-8299
  PubMedGoogle Scholar
• 34 Popp E, Padosch S A, Vogel P. Effects of intracerebroventricular application of brain-derived neurotrophic factor on cerebral recovery after cardiac arrest in rats.  Crit Care Med. 2004;  32 S359-S365
  PubMedGoogle Scholar
• 35 Böttiger B W, Bode C, Kern S et al.. Efficacy and safety of thrombolytic therapy after initial unsuccessful cardiopulmonary resuscitation: a prospective clinical trial.  Lancet. 2001;  357 1583-1585
  CrossrefPubMedGoogle Scholar
• 36 Spohr F, Arntz H R, Bluhmki E et al.. International multicenter trial protocol to assess the efficacy and safety of tenecteplase during cardiopulmonary resuscitation in patients with out-of-hospital cardiac arrest: The Thrombolysis in Cardiac Arrest (TROICA) Study.  Eur J Clin Invest. 2005;  35 315-323
  Google Scholar
• 37 Krep H, Brinker G, Schwindt W et al.. Endothelin type A-antagonist improves long-term neurological recovery after cardiac arrest in rats.  Crit Care Med. 2000;  28 2873-2880
  PubMedGoogle Scholar
• 38 Hachimi-Idrissi S, Corne L, Huyghens L. The effect of mild hypothermia and induced hypertension on long-term survival rate and neurological outcome after asphyxial cardiac arrest in rats.  Resuscitation. 2001;  49 73-82
  CrossrefPubMedGoogle Scholar
• 39 Safar P, Xiao F, Radovsky A et al.. Improved cerebral resuscitation from cardiac arrest in dogs with mild hypothermia plus blood flow promotion.  Stroke. 1996;  27 105-113
  CrossrefPubMedGoogle Scholar
• 40 Leonov Y, Sterz F, Safar P et al.. Hypertension with hemodilution prevents multifocal cerebral hypoperfusion after cardiac arrest in dogs.  Stroke. 1992;  23 45-53
  PubMedGoogle Scholar
• 41 Colbourne F, Grooms S Y, Zukin S et al.. Hypothermia rescues hippocampal CA1 neurons and attenuates down-regulation of the AMPA receptor GluR2 subunit after forebrain ischemia.  Proc Natl Acad Sci U S A. 2003;  100 2906-2910
  CrossrefPubMedGoogle Scholar
• 42 The Hypothermia After Cardiac Arrest Study Group . Mild therapeutic hypothermia to improve the neurological outcome after cardiac arrest.  N Engl J Med. 2002;  346 549-556
  CrossrefPubMedGoogle Scholar
• 43 Bernard S A, Gray T W, Buist M D et al.. Treatment of comatose survivors of out-of-hospital arrest with induced hypothermia.  N Engl J Med. 2002;  346 557-563
  CrossrefPubMedGoogle Scholar
• 44 International Liaison Committee on Resuscitation . Therapeutic hypothermia after cardiac arrest: an advisory statement by the advanced life support task force of the International Liaison Committee on Resuscitation.  Circulation. 2003;  108 118-121
  CrossrefPubMedGoogle Scholar
• 45 Vila N. A genetic approach to ischemic stroke therapy.  Cerebrovasc Dis. 2004;  17(suppl 1) 63-69
  CrossrefPubMedGoogle Scholar
• 46 Kagansky N, Levy S, Knobler H. The role of hyperglycemia in acute stroke.  Arch Neurol. 2001;  58 1209-1212
  CrossrefPubMedGoogle Scholar

David M GreerM.D. 

Department of Neurology, Massachusetts General Hospital

32 Fruit Street, Boston, MA 02114-2620